Johnson Grass Allergy: 5 Named Allergens, 30+ States, No Timothy Coverage

Johnson grass (Sorghum halepense) is a perennial warm-season grass native to the Mediterranean that was introduced to the United States as a forage crop and has since spread to become one of the world's worst invasive plants. As a member of subfamily Panicoideae, it produces Group 1 beta-expansin allergens and five other WHO/IUIS-characterized proteins that trigger IgE-mediated allergic responses in susceptible individuals. The plant grows to 7 feet tall along roadsides and agricultural margins and pollinates from July through September. Its combination of wide geographic distribution across 30-plus states, massive pollen output, and the diagnostic challenge posed by its Group 5 absence make it a clinically significant but frequently unrecognized allergy trigger.

Johnson grass is a federal noxious weed classified by the USDA as problematic in more than 30 US states, with the heaviest infestations in the southern and eastern regions from Texas through the Mid-Atlantic and up into the lower Midwest. It is most abundant in Oklahoma, Texas, Tennessee, Arkansas, Louisiana, Mississippi, Alabama, Georgia, the Carolinas, Virginia, Kansas, and Missouri. The plant spreads aggressively via both wind-dispersed seed and underground rhizomes, making eradication extremely difficult once established. Its continued spread into new territories means the geographic range of Johnson grass allergy risk is gradually expanding northward under warming climate conditions.

Timothy grass allergy shots provide incomplete coverage for Johnson grass sensitization. Timothy (Phleum pratense) is a Pooideae species, and its immunotherapy effectiveness relies primarily on the Group 5 allergen (Phl p 5) cross-reactivity shared across Pooideae species. Johnson grass is a Panicoideae species that completely lacks Group 5 allergens, so the primary cross-reactivity mechanism of Timothy immunotherapy does not apply. There is partial overlap through shared Group 1 beta-expansin allergens, but this provides only incomplete coverage. If you experience continued grass-like symptoms in July through September while on Timothy-based immunotherapy, specifically ask your allergist about Johnson grass IgE testing and whether a Panicoideae representative should be added to your treatment formulation.

Johnson grass and ragweed are completely different plant species with entirely different allergen proteins. Johnson grass (Sorghum halepense) is a Panicoideae grass with Group 1 beta-expansin proteins as its major allergens. Ragweed (Ambrosia artemisiifolia) is an Asteraceae weed with pectate lyase Amb a 1 as its dominant allergen — a completely different protein family with no cross-reactivity to grass proteins. The clinical confusion arises because both pollinate in summer and early fall, creating overlapping symptom windows from July through October. Component testing can distinguish them: grass IgE (Phl p 1 or Johnson grass g10) vs. ragweed IgE (Amb a 1) identifies which species is driving symptoms, and immunotherapy can target each separately.

Yes, Johnson grass pollen is a documented asthma trigger for sensitized patients. The IgE-mediated mast cell activation that drives nasal and ocular symptoms can simultaneously involve bronchial mast cells in patients with lower airway involvement, producing bronchoconstriction, wheezing, chest tightness, and reduced peak flow. This is the standard mechanism of pollen-induced allergic asthma, and Johnson grass functions similarly to other grass pollens in this regard. The July through September season is also associated with high temperatures, increased ozone levels, and reduced air quality in many southern states, creating a compounded respiratory burden for asthmatic patients. Any asthmatic living in Johnson grass territory should discuss preemptive controller medication optimization with their allergist before July.

Johnson grass pollen contains five WHO/IUIS-recognized allergens. Sor h 1 is the Group 1 beta-expansin and the dominant major allergen, sensitizing the vast majority of Johnson grass-allergic patients. Sor h 2 is a Group 2 allergen with moderate sensitization rates. Sor h 7 is a polcalcin, a pan-allergen that cross-reacts with polcalcins from multiple plant species in polysensitized patients. Sor h 13 is a Group 13 polygalacturonase — notably present in both Panicoideae and Pooideae grasses, making it a potential cross-reactivity bridge across subfamilies. Sor h 23 rounds out the characterized allergen set. This molecular depth makes Johnson grass the best-characterized sour grass and the molecular reference for understanding Panicoideae allergy as a clinical category.

Johnson grass (Sorghum halepense) is a wild relative of cultivated sorghum (Sorghum bicolor), and the two species share allergen proteins including the Group 1 beta-expansin major allergen. Pollen allergy to Johnson grass and sorghum is expected to cross-react substantially because of their close botanical relationship within the same genus. However, sorghum as a food crop is a different sensitization context: occupational sorghum grain allergy and sorghum pollen allergy are separate clinical entities with different exposure routes and different patient populations. For most allergy patients in the US, Johnson grass pollen allergy from airborne pollen is the relevant clinical concern rather than food sorghum sensitization. If you have occupational exposure to sorghum grain handling in addition to outdoor pollen exposure, mention both to your allergist for a complete sensitization assessment.

Johnson grass and Bermuda grass are both warm-season sour grasses that pollinate in summer, but they belong to different subfamilies (Panicoideae versus Chloridoideae) with distinct geographic distributions and allergen profiles. Bermuda grass (Cyn d 1) is the dominant allergen in the deep South, Southwest, and California, where it can pollinate almost year-round. Johnson grass peaks July through September along roadsides and agricultural margins across 30-plus states, including many areas of the upper South and Mid-Atlantic where Bermuda grass is less prevalent. Component testing for Cyn d 1 (Bermuda, Chloridoideae marker) and Johnson grass specific IgE (g10) can distinguish sensitization to each. Some patients are sensitized to both, requiring immunotherapy formulations that include representatives of both Chloridoideae and Panicoideae subfamilies.

Eating sorghum grain products is not a risk factor for pollen-allergic patients under ordinary circumstances. Johnson grass pollen allergy is an IgE-mediated response to inhaled airborne proteins, not to dietary sorghum. The proteins responsible for pollen IgE reactivity (Sor h 1, a beta-expansin) are not identical to food proteins in sorghum grain, and cooking thoroughly denatures any residual allergenic proteins in grain products. Unless you have a documented food allergy to sorghum grain specifically — which is a separate and distinct clinical entity from pollen allergy — eating sorghum foods such as sorghum flour products, sorghum syrup, or whole sorghum grain is not contraindicated for Johnson grass pollen-allergic patients. Discuss any suspected food reactions with your allergist for proper evaluation.

Yes, children can develop Johnson grass allergy, particularly those living in rural and suburban areas of the southern and eastern US where the weed is abundant. Grass pollen sensitization typically emerges in early school-age children after several years of seasonal pollen exposure, often between ages 3 and 8. Children with atopic backgrounds — eczema, food allergy, or parental hay fever — are at higher risk of developing grass sensitization. Because children are often outdoors during summer, their exposure to July through August Johnson grass pollen can be substantial during the years when sensitization develops. Pediatric allergy evaluation is appropriate for any child with recurrent summer hay fever, and sublingual immunotherapy drops are particularly suitable for younger children who cannot tolerate allergy injection protocols.